Hyperlipidaemia and cardioprotection: Animal models for translational studies

Andreadou, Ioanna ✉; Schulz, Rainer; Badimon, Lina; Adameová, Adriana; Kleinbogard, Petra; Lecour, Sandrine; Nikolaou, Panagiota-Efstathia; Falcão-Pires, Ines; Vilahur, Gemma; Woudberg, Nicholas; Heusch, Gerd; Ferdinandy, Péter ✉ [Ferdinandy, Péter (Farmakológia, mol...), author] Department of Pharmacology and Pharmacotherapy (SU / FM / I)

English Survey paper (Journal Article) Scientific
Published: BRITISH JOURNAL OF PHARMACOLOGY 0007-1188 1476-5381 177 (23) pp. 5287-5311 2020
  • SJR Scopus - Pharmacology: D1
Identifiers
Hyperlipidaemia is a well established risk factor for cardiovascular diseases, and therefore many animal modelshave been developed to mimic the human abnormal elevation of blood lipid levels. In parallel, extensive research for the alleviation of ischaemia/reperfusion injury has revealed that hyperlipidaemia is a major comorbidity that attenuates the cardioprotective effect of conditioning strategies (pre-conditioning, post-conditioning, remote conditioning) andthat of pharmacological interventions by interfering with cardioprotective signallingpathways. In the present review article, we summarize the existing data on animal models of hypercholesterolaemia (total, low density and high-density lipoprotein abnormalities) and hypertriglyceridaemia used in ischaemia/reperfusion injury and protection from it. We also provide recommendations on preclinical animal models to be used for translations of the cardioprotective strategies into clinical practice.
Citation styles: IEEEACMAPAChicagoHarvardCSLCopyPrint
2025-04-14 03:11